Skip to main content

Table 2 Multivariate analysis of various inflammatory parameters

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Inflammatory parameters

OS

PFS

HR (95% CI)

P-value

HR (95% Cl)

P-value

Albumin levels(<41.5 g/L)

2.911(1.533–5.525)

0.001

2.025(1.278–3.208)

0.003

LMR(≤2.7)

1.966(1.100–3.513)

0.022

1.688(1.062–2.684)

0.027

CRP(>8.6 mg/L)

1.804(0.983–3.310)

0.037

1.588(0.993–2.541)

0.054

NLR(>4.6)

 

0.306

 

0.183

PLR(>187.4)

 

0.604

 

0.205

Fibrinogen levels (>3.8 g/L)

 

0.800

 

0.266

  1. Abbreviations: OS Overall survival, PFS Progression-free survival, HR Hazard Ratio, 95% Cl, 95% confidence limits, LMR Lymphocyte-to-monocyte Ratio, CRP C-reactive protein, NLR Neutrophil-to- lymphocyte ratio, PLR Platelet-to- lymphocyte ratio